논문KCI 등재
Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
참고문헌 (10)
관련 논문AI추천
Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction- associated steatotic liver disease and cirrhosis”Weixiong Zhu, Wence Zhou, Xuefan Zeng, Yusheng Cheng, Zengxi Yang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제3호Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction- associated steatotic liver disease and cirrhosis”Ailei Xu, Wei Wang, Yating Xie대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Correspondence to editorial on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”Linda Henry, Mindie H. Nguyen, Nicholas A. Rouillard대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Reply to correspondence on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”Jian-Gao Fan, Jing Zeng대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호A leap in the dark: Bariatric surgery for treatment of metabolic dysfunction-associated steatotic liver disease related cirrhosis: Editorial on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”Jian-Gao Fan, Jing Zeng대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Letter to the editor on “Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis”Hang Li, Xiao-Song Li, Xi-Ping Shen대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호
이 간행물의 다른 논문 (36건)
Current burden of MASLD, MetALD, and hepatic fibrosis among US adults with prediabetes and diabetes, 2017–2023Rohit Loomba, Aijaz Ahmed, Donghee Kimpp. 235-238What is new in the 2024 Chinese guidelines for fatty liver disease?Rui-Xu Yang, Jian-Gao Fan, Vincent Wai-Sun Wongpp. 239-246Classification of microvascular invasion of hepatocellular carcinoma: Different standards, common goals: Letter to the editor on “Classification of microvascular invasion of hepatocellular carcinoma: Correlation with prognosis and magnetic resonance imaging”Weiwei Shi, Hang Jiang, Yihui Rong, Tianshi Ma, Wei Chen, Wei Chenpp. 249-251Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction- associated steatotic liver disease and cirrhosis”Weixiong Zhu, Xuefan Zeng, Zengxi Yang, Yusheng Cheng, Wence Zhoupp. 252-253Mendelian randomization does not support the effects of G CSF on decompensated liver diseaseHong Wang, Hui Wang, Liling Li, Jinchang Huangpp. 254-258